Investment Thesis
MHV invests in UK-based health tech founders with global ambitions, enabling transatlantic growth by leveraging partnerships with leading NHS trusts and US health systems (e.g., Cedars-Sinai, Hartford HealthCare). The fund supports evidence generation for broader adoption, aligning portfolio companies with health systems from inception to scale.
Stage Focus
Early-stage to growth-stage health tech ventures
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Clinical innovators focused on adoption and scale of transformative health tech solutions
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
€4,130,000 - €7,350,000
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...